-+ 0.00%
-+ 0.00%
-+ 0.00%

Argus Research Downgrades Integra Lifesciences to Hold

Benzinga·04/15/2026 11:46:02
Listen to the news
Argus Research analyst David Toung downgrades Integra Lifesciences (NASDAQ:IART) from Buy to Hold.